Results 201 to 210 of about 67,058 (255)

Febrile Neutropenia in the Context of Clozapine-Induced Agranulocytosis (CIA) and Myelodysplastic Syndrome: Importance of a Multidisciplinary Approach. [PDF]

Cureus
Conchinha AF, Pack T, Rodrigues A, Lopes A, Santos A.   +4 more
europepmc   +1 more source

Therapy related myelodysplastic syndrome: a hematologic sequela of low dose methotrexate in rheumatoid arthritis. [PDF]

Oxf Med Case Reports
Gupta A, D V, Nawaz A, Hari V.
europepmc   +1 more source

Severe Hidradenitis Suppurativa and Subsequent Myelodysplastic Syndrome: A Case Report Highlighting Chronic Inflammatory Burden and Carcinogenic Risk. [PDF]

Cureus
Rosas García MR, Maldonado-Colin G, Achell Nava L, Barajas BD, Alanis R.   +4 more
europepmc   +1 more source

Minoxidil ameliorates myelodysplastic syndrome by targeting Wnt4 while sparing normal hematopoiesis. [PDF]

Cell Commun Signal
Shi X, Liu Y, Huang L, Ou Y, Chen X, Ling Y, Zhang Y, Lin Q.   +7 more
europepmc   +1 more source

Clinical Characteristics and Molecular Profiling of <i>SF3B1</i>-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice. [PDF]

Int J Mol Sci
Wang RR, Than H, Tham C, How GF, Khoo SJ, Tuy TT.   +5 more
europepmc   +1 more source

Distinct Pattern of Atypical Megakaryocytes in VEXAS Syndrome

International Journal of Laboratory Hematology, Volume 48, Issue 4, Page 713-714, August 2026.
Andrew Y. Sung, Jackson W. Douglas, Olga K. Weinberg, Sharon K. Germans, Weina Chen   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myelodysplastic Syndromes

Hematology, 2004
AbstractThe development of new therapeutic strategies for myelodysplastic syndromes (MDS) has gained new momentum fueled by improved characterization of the disease’s natural history and biology and by the recent US Food and Drug Administration (FDA) approval of the first agent with an indication for MDS.
Alan F, List, James, Vardiman, Jean-Pierre J, Issa, Theo M, DeWitte   +3 more
  +7 more sources

Myelodysplastic syndromes

Hematology and Cell Therapy, 1996
The authors review the epidemiological biological, diagnostic, prognostic and therapeutic aspects of myelodysplastic syndromes.
J F, San Miguel, G F, Sanz, T, Vallespí, M C, del Cañizo, M A, Sanz   +4 more
  +9 more sources